102 related articles for article (PubMed ID: 11141435)
1. [Acute hepatitis induced by candesartan].
Vallejo I; García Morillo S; Pamies E
Med Clin (Barc); 2000 Nov; 115(18):719. PubMed ID: 11141435
[No Abstract] [Full Text] [Related]
2. Candesartan and acute liver injury.
González-Jiménez D; Varela JM; Calderón E; Galindo J; González de la Puente MA
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):769-70. PubMed ID: 11214790
[No Abstract] [Full Text] [Related]
3. [Candesartan-induced cholestatic hepatitis: a case report].
Jiménez-Sáenz M; Arroyo Q; Sanjuan M; Herrerías JM
Gastroenterol Hepatol; 2010 Jan; 33(1):66-7. PubMed ID: 19713003
[No Abstract] [Full Text] [Related]
4. Noncholestatic acute hepatocellular injury following candesartan administration.
Lammel-Lindemann JA; Flores-Villalba E; Martagón AJ; DeObeso-Gonzalez E; Puente-Gallegos F
Br J Clin Pharmacol; 2018 Jan; 84(1):204-207. PubMed ID: 28841231
[TBL] [Abstract][Full Text] [Related]
5. [Angiotensin II antagonist treatment as a contributory cause of acute renal failure].
Nielsen LR
Ugeskr Laeger; 2003 Mar; 165(13):1368-9. PubMed ID: 12703286
[TBL] [Abstract][Full Text] [Related]
6. Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis.
Johansen TL; Kjaer A
BMC Nephrol; 2001 May; 2():1. PubMed ID: 11388887
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
[TBL] [Abstract][Full Text] [Related]
8. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
10. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
11. PATHOMORPHOLOGY OF THE MYOCARDIUM, KIDNEY AND LIVER IN SPONTANEOUSLY HYPERTENSIVE RATS TREATED WITH SHORT AND LONG-TERM USE RAMIPRIL AND CANDESARTAN.
Maruschak A; Shorikov E; Timofiichuk I; Davydenko I; Slobodyan K
Georgian Med News; 2018 Mar; (276):135-143. PubMed ID: 29697397
[TBL] [Abstract][Full Text] [Related]
12. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
Zanchetti A; Omboni S; Di Biagio C
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S57-9. PubMed ID: 9331009
[No Abstract] [Full Text] [Related]
13. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
Granger CB; Ertl G; Kuch J; Maggioni AP; McMurray J; Rouleau JL; Stevenson LW; Swedberg K; Young J; Yusuf S; Califf RM; Bart BA; Held P; Michelson EL; Sellers MA; Ohlin G; Sparapani R; Pfeffer MA
Am Heart J; 2000 Apr; 139(4):609-17. PubMed ID: 10740141
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
Franke H
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S61-2. PubMed ID: 9331010
[No Abstract] [Full Text] [Related]
15. Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome.
Haaland K
J Headache Pain; 2010 Apr; 11(2):167-9. PubMed ID: 20063032
[TBL] [Abstract][Full Text] [Related]
16. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trials of ACE inhibitors and ARB for treatment of patients with hypertension, heart failure, and diabetic nephropathy in Japan--special reference to the dosage schedule and adverse effects].
Kageyama S
Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):180-1. PubMed ID: 18421844
[No Abstract] [Full Text] [Related]
18. Candesartan for hypertension.
Med Lett Drugs Ther; 1998 Nov; 40(1040):109-10. PubMed ID: 9844624
[No Abstract] [Full Text] [Related]
19. Angioedema: 6 years experience with fourteen cases.
Taki M; Watanabe H; Hasegawa T; Bamba H; Shimada T; Hisa Y
Auris Nasus Larynx; 2010 Apr; 37(2):199-204. PubMed ID: 19709832
[TBL] [Abstract][Full Text] [Related]
20. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group.
Tanser PH; Campbell LM; Carranza J; Karrash J; Toutouzas P; Watts R
Am J Hypertens; 2000 Feb; 13(2):214-8. PubMed ID: 10701823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
